Prognostic value of cardiovascular disease status: The Leiden 85-plus study

Age

Volumn 35, Issue 4, 2013, Pages 1433-1444

  Van Peet, Petra G ^a   Drewes, Yvonne M ^a   De Craen, Anton J M ^a   Westendorp, Rudi G J ^a,b   Gussekloo, Jacobijn ^a   Ruijter, Wouter De ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Netherlands Consortium for Healthy Ageing   (Netherlands)

Author keywords

Aged 80 and over; Cardiovascular disease; Cardiovascular morbidity; Functional status . Mortality; Prevention

Indexed keywords

AGED; ANGINA PECTORIS; ARTERY SURGERY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; AGING; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; HEALTH SURVEY; MOTOR ACTIVITY; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE; TRENDS; VERY ELDERLY;

AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MORBIDITY; MOTOR ACTIVITY; NETHERLANDS; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84891667708     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-012-9443-5     Document Type: Article

References (50)

1. Alhusban A, Fagan SC (2011) Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother 9:143-152
2. Andrawes WF, Bussy C, Belmin J (2005) Prevention of cardiovascular events in elderly people. Drugs Aging 22:859-876
3. Anthierens, S., Tansens, A., Petrovic, M., & Christiaens, T (2010) Qualitative insights into general practitioners views on polypharmacy. BMC.Fam.Pract., 11, 65
4. Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, MacMahon S, Chalmers J (2006) Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke 37:1497-1502
5. Arnold SV, Spertus JA, Tang F, Krumholz HM, Borden WB, Farmer SA, Ting HH, Chan PS (2011) Statin use in outpatients with obstructive coronary artery disease. Circulation 124:2405-2410
6. Asberg S, Henriksson KM, Farahmand B, Asplund K, Norrving B, Appelros P, Stegmayr B, Asberg KH, Terent A (2010) Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke 41:1338-1342
7. Banerjee A, Mbamalu D, Ebrahimi S, Khan AA, Chan TF (2011) The prevalence of polypharmacy in elderly attenders to an emergency department-A problem with a need for an effective solution. Int J Emerg Med 4:22
8. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW (2006) International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA: J Am Med Assoc 295:180-189
9. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM, Roe MT (2009) Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 30:1195-1202
10. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, Wilson PWF, Alberts MJ, D'Agostino R, Liau CS, Mas JL, Röther J, Smith SC, Salette GV, Contant CF, Massaro JM, Steg P (2010) Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA: J Am Med Assoc 304:1350-1357
11. Cantril H (1965) The pattern of human concerns. Rutgers University Press, New Brunswick
12. Cardenas-Valladolid J, Martin-Madrazo C, Salinero-Fort MA, Carrillo de-Santa PE, Abanades-Herranz JC, de Burgos- Lunar C (2010) Prevalence of adherence to treatment in homebound elderly people in primary health care: a descriptive, cross-sectional, multicentre study. Drugs Aging 27:641-651
13. Castilla-Guerra L, Fernandez-Moreno MC, Alvarez-Suero J (2009) Secondary stroke prevention in the elderly: new evidence in hypertension and hyperlipidemia. Eur J Intern Med 20:586-590
14. de Craen AJ, Heeren TJ, Gussekloo J (2003) Accuracy of the 15- item geriatric depression scale (GDS-15) in a community sample of the oldest old. Int J Geriatr Psychiatry 18:63-66
15. Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck- Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D (2007) Effects of intensive versus moderate lipidlowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation 115:700-707
16. der Wiel AB, van Exel E, de Craen AJ, Gussekloo J, Lagaay AM, Knook DL, Westendorp RG (2002) A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J Clin Epidemiol 55:1119-1125
17. Dornbrook-Lavender KA, Pieper JA, Roth MT (2003) Primary prevention of coronary heart disease in the elderly. Ann Pharmacother 37:1654-1663
18. Ferrieres J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A (2006) Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol 112:302-307
19. Fleg JL, Aronow WS, Frishman WH (2011) Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol 8:13-28
20. Fried TR, Tinetti ME, Towle V, O'Leary JR, Iannone L (2011) Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med 171:923-928
21. Graham, I., Atar, D., Borch-Johnsen, K. et al. (2007). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur.- J.Cardiovasc.Prev.Rehabil., 14
22. Hassey A, Gerrett D, Wilson A (2001) A survey of validity and utility of electronic patient records in a general practice. BMJ 322:1401-1405
23. Hjemdahl P, Eriksson SV, Held C, Forslund L, Nasman P, Rehnqvist N (2006) Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Heart 92:177-182
24. Kempen GI, Miedema I, Ormel J, Molenaar W (1996) The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med 43:1601-1610
25. Kerr AJ, Broad J, Wells S, Riddell T, Jackson R (2009) Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 95:125-129
26. Kvan E, Pettersen KI, Landmark K, Reikvam A (2006) Treatment with statins after acute myocardial infarction in patients > or080 years: underuse despite general acceptance of drug therapy for secondary prevention. Pharmacoepidemiol Drug Saf 15:261-267
27. Macfarlane PW, Latif S (1996) Automated serial ECG comparison based on the Minnesota code. J Electrocardiol 29 (Suppl):29-34
28. Maroo BP, Lavie CJ, Milani RV (2008) Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike? Drugs Aging 25:649-664
29. McDermott MM (2007) The international pandemic of chronic cardiovascular disease. JAMA: J Am Med Assoc 297:1253-1255
30. Migliaccio-Walle, K., Stokes, M., Proskorovsky, I., Popovici-Toma, D., & El-Hadi, W. (2010). Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data. BMC.Cardiovasc.Disord., 10, 40.
31. Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, JagustW, Ives D, Dekosky ST, Kuller LH (2005) Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53:1101-1107
32. Newman AB, Arnold AM, Sachs MC, Ives DG, Cushman M, Strotmeyer ES, Ding J, Kritchevsky SB, Chaves PH, Fried LP, Robbins J (2009) Long-term function in an older cohort- The cardiovascular health study all stars study. J Am Geriatr Soc 57:432-440
33. Ray KK, Bach RG, Cannon CP, Cairns R, Kirtane AJ, Wiviott SD, McCabe CH, Braunwald E, Gibson CM (2006) Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. Eur Heart J 27:2310-2316
34. Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:e18-e209
35. Rosengren A,Wilhelmsen L, HagmanM,Wedel H (1998) Natural history of myocardial infarction and angina pectoris in a general population sample of middle-Aged men: a 16-year follow-up of the Primary Prevention Study, Goteborg. Sweden J Intern Med 244:495-505
36. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623-1630
37. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S (2007) One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA: J Am Med Assoc 297:1197-1206
38. Thomas JE, Tershakovec AM, Jones-Burton C, Sayeed RA, Foody JM (2010) Lipid lowering for secondary prevention of cardiovascular disease in older adults. Drugs Aging 27:959-972
39. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922-935
40. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL (2005) Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-Analysis. Stroke 36:2748-2755
41. Vaartjes, I., van Dis, I, Grobbee, D. E., & Bots, M. L. (2010). The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke. BMC.Cardiovasc.Disord., 10, 57
42. van Exel E, Gussekloo J, Houx P, de Craen AJ, Macfarlane PW, Bootsma-van der Wiel A, Blauw GJ, Westendorp RG (2002) Atherosclerosis and cognitive impairment are linked in the elderly. The Leiden 85-plus Study. Atherosclerosis 165:353-359
43. van Jaarsveld CH, Sanderman R, Miedema I, Ranchor AV, Kempen GI (2001) Changes in health-related quality of life in older patients with acute myocardial infarction or congestive heart failure: a prospective study. J Am Geriatr Soc 49:1052-1058
44. van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A (2005) Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 365:2098-2104
45. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA (2002) Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 33:901-906
46. Wald NJ, Simmonds M, Morris JK (2011) Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS One 6:e18742
47. Waldstein SR, Wendell CR (2010) Neurocognitive function and cardiovascular disease. J Alzheimers Dis 20:833-842
48. Wenger, N. K. & Lewis, S. J (2010) Use of statin therapy to reduce cardiovascular risk in older patients. Curr.Gerontol. Geriatr.Res., 915296
49. Wilson PW (2011) Prediction of cardiovascular disease events. Cardiol Clin 29:1-13
50. Wilson PW, d'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847